Wearable Injectors Market Forecast, Share, Trends, and Growth 2031

The Wearable Injectors Market was valued at US$ 8.98 billion in 2023 and is expected to reach US$ 21.61 billion by 2031. The market is expected to register a CAGR of 11.6% in 2023–2031. Integration with telemedicine will likely remain key trend in the wearable injector market.

Wearable Injectors Market Analysis

The rising prevalence of chronic illnesses is a factor driving the market for wearable injectors. The aging population also utilizes wearable medical technology because acute and chronic illnesses are becoming more commonplace worldwide. The emergence of wearable medical devices coincided with the COVID-19 pandemic.  For instance, according to the World Health Organization, approximately 422 million individuals globally have diabetes, with the majority residing in low- and middle-income nations. The disease is directly responsible for 1.5 million deaths annually.

Wearable Injectors Market Overview

The field of wearable medical devices has a bright future due to technological developments, rising health consciousness regarding these devices, and a growing need for individualized healthcare. The market for wearable injection devices is anticipated to grow in emerging countries due to technological advancements and innovations in these devices. Increases in cardiovascular disease and diabetes are predicted to accelerate market expansion greatly. For example, it is anticipated that in China, the percentage of people aged 20 to 79 who have diabetes will rise from 8.2% to 9.7% between 2020 and 2030.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Wearable Injectors Market: Strategic Insights

Wearable Injectors Market

• 
  CAGR (2023 - 2031)

  11.6%
• Market Size 2023
  US$ 8.98 Billion
• Market Size 2031
  US$ 21.61 Billion

Market Dynamics

GROWTH DRIVERS

• Surge in Demand for Wearable Injectors

FUTURE TRENDS

• Integration With Telemedicine

OPPORTUNITIES

• New Product Launches and Approval

Key Players

• Amgen Inc
• Medtronic
• BD
• Insulet Corporation
• Gerresheimer AG Sensile Medical
• West Pharmaceutical Services Inc
• Ypsomed AG
• Tandem Diabetes Care Inc
• CeQur SA
• Debiotech S A

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• On-Body Injectors
• Off-Body Injectors

Application

• Diabetes
• Oncology
• Cardiovascular Disease
• Autoimmune Disease
• Other Applications

End User

• Hospitals and Clinics
• Homecare Settings
• Other End Users

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Wearable Injectors Market Drivers and Opportunities

Surge in Demand for Wearable Injectors to Favor Market

Companies are engaged in providing wearable health technology to their consumers and ensuring it is beneficial. The market for wearables in the healthcare ecosystem is growing rapidly. Based on information from the National Institutes of Health, about 30% of US adults use wearable medical technology, and almost half do so daily to address complicated medical conditions. According to reports, several businesses are competing to be the first to market wearable blood pressure monitors, which have the potential to replace traditional hospital testing. With its promise of seamless integration into daily routine, the wearable injectors industry is indispensable in revolutionizing healthcare. These devices have developed and gained traction. Smart medical systems are becoming possible due to advancements in embedded systems, sensing technologies, nanotechnologies, and miniaturization. Easy to use and comfortable to use, injectors come with features like flexible dosing, water resistance, and automatic warming of refrigerated drugs. The need for injectors has grown as a result of these advantages.

New Product Launches and Approval – An Opportunity in the Wearable Injectors Market

The healthcare industry is constantly developing significantly due to the increasing demand for wearable injectors from a large population globally, which has increased new product development, product launches, and approvals globally. Additionally, major market players are involved in research and development activities to ensure the innovation and development of efficient products. In recent years, various developments, such as product launches and approvals, have taken place in the market, likely to create ample opportunities. For instance, in February 2024, leading pharmaceutical technology company LTS LOHMANN Therapie-Systeme AG announced that Coherus BioSciences, Inc., one of its customers, has introduced the UDENYCA on-body injector (OBI), which makes use of the LTS Sorrel wearable drug delivery platform.) The biosimilar pegfilgrastim, known as UDENYCA (pegfilgrastim-cbqv), is given the day following chemotherapy to reduce the risk of infection, as indicated by febrile neutropenia. The U.S. Food and Drug Administration (FDA) approved the UDENYCA OBI in December 2024.

Wearable Injectors Market Report Segmentation Analysis

Key segments contributing to the wearable injectors market analysis derivation are type, application, and end user.

• Based on type, the wearable injectors market is divided into on-body injectors, off-body injectors. The on-body injectors segment held a larger market share in 2023.
• By application, the market is segmented into diabetes, oncology, cardiovascular disease, autoimmune disease, other applications. The oncology segment held the largest share of the market in 2023.
• Based on end user, the wearable injectors market is categorized into hospitals and clinics, homecare settings, other end users.

Wearable Injectors Market Share Analysis by Geography

The wearable injectors market report's geographic scope is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the wearable injectors market. In North America, the U.S. is the largest market for wearable injectors in 2023.  An increase in the prevalence of chronic illnesses such as diabetes, cancer, oncology, cardiovascular diseases, and others characterizes the growing North American market. In addition to the creation of novel products and the existence of significant market participants in the area. Furthermore, the growing incidence of diabetes in the United States is anticipated to support the expansion of the wearable injector market within the nation. According to the Centers for Disease Control and Prevention's (CDC) 2021 National Diabetes Statistics report, approximately 37.3 million Americans had diabetes, of which 1.45 million were type 1 diabetics. In North America, wearable injector demand is predicted to increase due to the rising incidence of cancer. For example, in 2022, the American Cancer Society reported that approximately 1.9 million new cancer cases were identified. Among the most prevalent cancers in the nation are melanoma, prostate, and breast cancers. Furthermore, the development of medical technology will create significant opportunities for the wearable injector market in North America.

Wearable Injectors Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Wearable Injectors Market News and Recent Developments

The wearable injectors market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for wearable injectors and strategies:

• Ypsomed enters a partnership with ten23 health, a global Swiss contract development and manufacturing organization. The aim of this collaboration is to advance the commercialization of the YpsoDose wearable injector for the subcutaneous self-injection of large-volume doses. ten23’s drug development, filling and device assembly expertise will significantly contribute to the product offering. (Source: Ypsomed Company Name, Press Release, 2024)
• Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions with reliable innovations that put patients at the center of care, is pleased to announce the successful completion of sale and transition of its wearable injectors business to LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems. The strategic acquisition marks a milestone for both organizations and sets the stage for further advancements in the field of patient-centric drug delivery systems. (Source: Eitan Medical Company Name, Newsletter, 2023)

Wearable Injectors Market Report Coverage and Deliverables

The “Wearable Injectors Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles